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Thirty-nine hemodialysis patients with permanent central venous 
catheters were analyzed for bacterial catheter colonization compar-
ing different catheter-lock strategies. The closed needleless Tego con-
nector with sodium chloride lock solution was significantly more 
frequently colonized with bacteria than the standard catheter caps 
with antimicrobially active citrate lock solution (odds ratio, 0.22 
[95% confidence interval, 0.07-0.71]; P = .011). 
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Catheter-related bloodstream infection (CRBSI) is a serious 
complication in patients with tunneled long-term central ve-
nous catheters (CVCs) undergoing chronic hemodialysis.1 
Proper aseptic technique when manipulating CVCs or the use 
of antimicrobial lock solutions is recommended to reduce the 
incidence of CRBSIs.2 The impact of closed needleless devices 
to prevent CRBSI is controversial.3 The Tego system by ICU 
Medical is a needleless luer lock connector device for he-
modialysis CVCs that is approved by the US Food and Drug 
Administration. This connector is locked with saline solution 
and remains in place for 3 consecutive hemodialysis sessions, 
reducing manipulation of the catheter hub, an important 
source of intraluminal colonization of long-term CVCs and 
subsequent CRBSI.4'5 
In August 2008, the Tego connector system was introduced 
in all patients undergoing hemodialysis over a permanent 
tunneled CVC at the dialysis unit at the University Hospital 
Basel, a tertiary teaching hospital in Switzerland. Within rou-
tine surveillance after introduction of the Tego system, an 
increase of positive blood cultures drawn from the hemo-
dialysis CVC was detected. 
Subsequently, reports of high rates of CRBSI associated 
with the use of closed needleless mechanical valve systems 
were published.3 We therefore performed a sequential obser-
vational study from 2010 until 2012 to determine the colo-
nization rate of permanent tunneled hemodialysis CVCs with 
different catheter connector (Tego vs conventional closing 
caps [CCCs]) and lock solution (sodium chloride vs citrate) 
strategies. 
M U N I C A T I O N 
M E T H O D S 
Study Setting, CVC Locking Techniques, 
and Infection Control Activities 
From August 2008 to June 2010, the Tego closed needleless 
connector device system (ICU Medical) was used for all he-
modialysis CVCs, according to the manufacturers' instruc-
tions: disinfection of the connector injection site with ethanol 
swabs 80% (v/v) before and after each use, locking of each 
catheter branch with 2 mL of sterile 0.9% sodium chloride 
between hemodialysis sessions, and changing the Tego every 
7 days before the fourth dialysis." In July 2010, the Tego 
devices of all hemodialysis CVCs were replaced with CCCs 
(Discofix closing cap, Braun). CCC catheter hubs were dis-
infected with octenidine-containing solutions before attach-
ment and after detachment of a device. Catheter branches 
were blocked with 2 mL of citrate lock solution: 46.7% citrate 
until April 2011 and 30% citrate thereafter to reduce the risk 
of dangerous hypocalcemias in case of accidental citrate flush-
ing. CCCs were changed after each dialysis session (Table 1). 
Standard infection control protocols were used with all 
connector systems when manipulating dialysis catheters.2 An 
additional infection prevention program was implemented in 
the dialysis unit from August 2010 until April 2011 (during 
this period, CCCs 46.7% citrate was in use) and included the 
following interventions: additional hand disinfectant dis-
pensers were installed to facilitate hand hygiene, improved 
CVC care sets were implemented for catheter manipulation, 
and teaching about aseptic catheter management for health-
care workers was provided. 
Microbiological Culture of Catheter Lock Solutions 
Catheter lock solutions were examined for bacterial growth 
at 3 serial time points using 3 different locking strategies 
(Table 1): (1) Tego needleless connector device with 0.9% 
sodium chloride lock solution (June 28-29, 2010), (2) CCCs 
with 46.7% citrate lock solution (August 9-10, 2010) before 
infection prevention program, and (3) CCCs with 30% citrate 
lock solution after completion of the infection prevention 
program (June 6-7, 2011). Five milliliters of blood, including 
the lock solution from the arterial and the venous branch, 
was aseptically drawn in aerobic blood culture bottles (BacT/ 
ALERT) and incubated for 5 days at 37°C. Species identifi-
cation of positive cultures was done using the Vitek system 
(bioMerieux). 
Colonization was defined as any positive culture of a lock 
solution. Colonized CVCs were not treated with systemic 
antibiotic or antibiotic lock. 
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TABLE 1. Baseline Characteristics and Results of Tego 0.! 
CCCs 30% Citrate Groups 
Sodium Chloride, Conventional Closing Caps (CCCs) 46.7% Citrate, and 
Tego 0.9% sodium chloride CCCs 46.7% citrate before IPP CCCs 30% citrate after IPP 
No. of patients 
Age, median (range), years 
Gender, female (%) 
Time in use 
No. of catheter-days' 
Date of lock solution culture 
Lock solution 
Disinfection of CVC hub 
Exchange of device 
Catheter colonization (%) 
No. of microorganisms isolated 
Microorganisms frequency 
31 
68 (29-87) 
22 (71) 
August 15, 2008-July 5, 2010 
12,512 
June 26-July 5, 2010 
0.9% sodium chloride 
Ethanol 80% (v/v) 
Before fourth dialysis 
16 (52) 
19 
17 CoNS, 1 Streptococcus san-
guinis, 1 Micrococcus 
26 
67 (46-87) 
18 (69) 
July 6, 2010-March 31, 2011 
6,994 
August 9-10, 2010 
46.7% citrate 
Octenidine dihydrochloride-
containing solution 
After each dialysis 
5 (19)b 
7 
4 CoNS, 1 Enterococcus faecalis, 
1 Enterobacter cloacae, 1 Pseu-
domonas aeruginosa 
30 
68 (46-89) 
20 (67) 
April 1, 2011-June 1, 2012 
12,840 
June 6-7, 2011 
30% citrate 
Octenidine dihydrochloride-
containing solution 
After each dialysis 
2(7) ' 
2 
1 CoNS, 1 E. faecalis 
NOTE. Infection prevention program (IPP) from September 2010 to April 2011. CI, confidence interval; CoNS, coagulase-negative 
staphylococci; OR, odds ratio. 
* Catheter-days were calculated for each group for the period during which the connector lock solution system was in use. 
b
 Between Tego and CCCs 46.7% citrate: OR, 0.22 (95% CI, 0.07-0.71); P = .011. 
c
 Between Tego and CCCs 30% citrate: OR, 0.07 (95% CI, 0.01-0.35); P = .001. 
Statistical Analysis 
We performed logistic generalized estimating equations mod-
eling, using the lock strategies as the covariate and the pres-
ence of colonization as the outcome. On the basis of the 
generalized estimating equations, we derived odds ratios 
(ORs) with corresponding 95% confidence intervals (CIs). 
Values of P < .05 were considered statistically significant. 
RESULTS 
During the study period, a total of 39 patients received he-
modialysis by permanent tunneled, double-lumen CVC. 
Thirty-one patients had the Tego connector system at the first 
screening date in June 2010. After changing the Tego system 
to the CCCs system with 46.7% citrate lock solution, 26 pa-
tients could be screened in August 2010 before the infection 
prevention program started. Five patients of the initial pop-
ulation could not be analyzed because of catheter removal. 
The third screening was done in 30 patients with CCCs and 
30% citrate lock in June 2011 after completion of the infection 
prevention program (Table 1). 
In the Tego group, 16 of 31 patients (52%) had bacterial 
growth of at least 1 microorganism from the sodium chloride 
lock solution. In comparison, the colonization rate of the 
patients with the CCCs and citrate lock was significantly 
lower: in the CCCs group with 46.7% citrate lock, only 5 of 
26 (19%) patients had positive cultures (OR, 0.22 [95% CI, 
0.07-0.71]; P = .011); in the CCCs group with 30% citrate 
lock, 2 of 30 (7%) catheters were tested positive (OR, 0.07 
[95% CI, 0.01-0.35]; P = .001; Figure 1). 
Nineteen patients underwent all 3 screenings without in-
tercurrent catheter replacements. The colonization rate be-
tween the 3 groups was comparable to the above mentioned 
(data not shown). 
Coagulase-negative staphylococci were the most common 
pathogens detected in all 3 groups (Tego, 89%; CCCs 46.7% 
citrate, 75%; CCCs 30% citrate, 50%; Table 1). The number 
of CRBSIs during the study period was analyzed retrospec-
tively and showed no significant difference between the 3 
groups (CRBSIs per 1,000 catheter-days: Tego, 0.24; CCCs 
46.7% citrate, 0.28; CCCs 30% citrate, 0.16). 
D I S C U S S I O N 
In our study, we found a significantly higher colonization rate 
of more than 50% of the saline lock solution in patients with 
the Tego needleless connector device compared with the 
46.7% and 30% citrate lock solutions with CCCs. Several 
reasons may explain our findings. The antimicrobial potency 
of the lock solutions might have a considerable impact on 
catheter colonization. With the Tego connector, the manu-
facturer recommends 0.9% sodium chloride as the lock so-
lution, which does not prevent bacterial growth. In contrast, 
citrate has antimicrobial activity and has been advocated for 
hemodialysis CVC locking.6,7 It would be interesting to use 
citrate lock solution in conjunction with the Tego device; 
however, to date, this procedure is not supported by the 
manufacturer. 
The implementation of an active surveillance program at 
the dialysis unit—including microbiological examination of 
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*p=0.001 
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FIGURE l. Percentage of colonized central venous catheters (CVCs) with the 3 catheter lock strategies of all 39 patients. Absolute numbers 
and percentages of sterile and colonized CVCs are indicated. Values of P< .05 were considered statistically significant. CCC, conventional 
closing cap; IPP, infection prevention program. 
the catheter lock solution and the change from the Tego so-
dium chloride to the CCCs 46.7% citrate lock system—could 
have lead to improved hygienic catheter management with 
consequently lower CVC colonization rates with the CCCs. 
Reduction of nosocomial infections by surveillance has been 
demonstrated by the Study on the Efficacy of Nosocomial 
Infection Control (SENIC).8 The infection prevention pro-
gram, which was implemented after microbiological screening 
of the 46.7% citrate lock solution, might explain the lower 
colonization rate of the 30% citrate lock solutions, empha-
sizing the importance of surveillance and infection prevention 
programs to reduce CRBSI.9 However, statistical analysis be-
tween the CCCs 46.7% and 30% citrate group was not per-
formed because of model overfit due to the low number of 
colonized catheters. 
Previous studies showed a clear correlation between cath-
eter colonization and CRBSI.10 Although we found a signif-
icantly lower colonization rate of the CCCs citrate compared 
with the Tego sodium chloride lock system, we could not 
demonstrate a reduction of CRBSIs. However, our study was 
not designed to detect CRBSI; data about CRBSI were col-
lected retrospectively, and the CRBSI rate was very low in all 
3 groups (overall, 0.21 CRBSIs per 1,000 catheter-days). 
In conclusion, infection prevention programs and an an-
timicrobial active lock solution such as citrate may consid-
erably reduce the bacterial colonization rate of permanent 
hemodialysis CVC. The ease of use of closed needleless con-
nection devices from the Tego type without an antimicrobial 
active lock should be balanced against the risk of infections, 
since these are usually preceded by colonization. 
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